Výsledky vyhledávání - "D, Van Soolingen"

Akademický článek

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area

Autor: R. M. Anthony, E. Tagliani, V. Nikolayevskyy, R. de Zwaan, A. Mulder, M. Kamst, C. Ködmön, M. J. van der Werf, D. Cirillo, D. van Soolingen

Publikováno v: Microbiology Spectrum, Vol 11, Iss 1 (2023)

ABSTRACT Here, we report the development and key features of the first external quality assessment (EQA) scheme for Mycobacterium tuberculosis whole-genome sequencing (WGS). The results of four rounds (2017 to 2020) of implementation within the Europ

Externí odkaz: https://doaj.org/article/beef0a0ed8c8474b9b585ce5ab47b5e7

Zobrazit plný text záznamu

Akademický článek

Corrigendum to ‘Should treatment of low-level rifampicin mono-resistant tuberculosis be different?’ [JCTUBE 23 (2021) 100241]

Autor: F.A. Gopie, E. Commiesie, W.C.M. de Lange, D. van Soolingen, S.G.S. Vreden, G. de Vries

Publikováno v: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss , Pp 100245- (2021)

Externí odkaz: https://doaj.org/article/352812c6a7574f6e87c629bef522f974

Zobrazit plný text záznamu

Akademický článek

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Autor: F.A. Gopie, E. Commiesie, S. Baldi, M. Kamst, D. Kaur, W.C.M. de Lange, P.S. Pinas, D. Stijnberg, M. Wongsokarijo, C.W.R. Zijlmans, R. de Zwaan, D. van Soolingen, S.G.S. Vreden, G. de Vries

Publikováno v: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 23, Iss , Pp 100222- (2021)

Background: Rifampicin resistant tuberculosis (RR-TB) was frequently detected in Suriname after the introduction of Xpert MTB/RIF in 2012. Subsequent phenotypic drug-susceptibility testing (DST) was not conclusive at that moment, while RR-TB patients

Externí odkaz: https://doaj.org/article/68f7aba9c32c4663acfc5a07f1c63b3e

Zobrazit plný text záznamu